Breaking News, Collaborations & Alliances

TriLink, Alphazyme Launch Novel RNA Polymerase for Safer mRNA Production

CleanScribe RNA Polymerase is designed to reduce the formation of double-stranded RNA (dsRNA) during in vitro transcription (IVT) of mRNA.

Author Image

By: Charlie Sternberg

Associate Editor

Maravai LifeSciences subsidiaries TriLink BioTechnologies and Alphazyme have jointly introduced CleanScribe RNA Polymerase, a novel enzyme designed to significantly reduce the formation of double-stranded RNA (dsRNA) during in vitro transcription (IVT) of mRNA. This innovation aims to enhance the safety and efficacy of mRNA-based therapeutics.   dsRNA is an unwanted byproduct of IVT that can trigger adverse inflammatory responses in host cells. CleanScribe RNA Polymerase, a novel DNA-dependent...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters